Abbott is recalling the Ellipse Implantable Cardioverter Defibrillators (ICDs) because electrical failures have been identified and determined to be due to a faulty manufacturing process, causing...
HRS
This channel contains news about the Heart Rhythm Society (HRS), including coverage of its annual meeting and links to recently released practice guidelines. The HRS is a leading resource on cardiac pacing and electrophysiology.
-
-
Pierre Qian, MBBS, cardiac electrophysiologist fellow, Brigham and Women's Hospital, explains how...
-
MRI-compatible ICDs is a growing trend in the market. This example is Biotronik's Lumas 740 ICD.
This is a brief overview of updates on implantable cardioverter defibrillators (ICD), ...
-
News | Leads Implantable Devices | August 05, 2019
August 5, 2019 — Abbott is recalling the Ellipse...
Videos | EP Lab | July 25, 2019
A physician explaining an implantable cardioverter defibrillator (ICD) to a patient. Image courtesy of Biotronik.
Feature | Implantable Cardioverter Defibrillator (ICD) | May 24, 2019 | Dave Fornell, Editor
This is a brief overview of updates on...
Sponsored Content
New cardiac monitoring technologies allow for longer duration data collection. The Medtronic Reveal Linq implantable cardiac monitor allows for 24/7 monitoring for up to three years. This might not be necessary for most patients, and there are several newer Holter monitors that can record up to several days or several weeks of data in real-time.
Blog | ECG Wireless Remote Access | May 23, 2018
New patient monitoring technologies with wireless connectivity have enabled a revolution in cardiac event and...
Technology | Analytics Software | May 17, 2019
May 17, 2019 — Digital healthcare company Murj announced the availability of the Murj...
Acutus Medical's acquisition of Rhythm Xience brings the Flextra steerable introducer sheath into Acutus Medical's product portfolio.
News | EP Mapping and Imaging Systems | May 17, 2019
May 17, 2019 — At the 40th annual Heart Rhythm...
Sponsored Content
An example of the new generation of inexpensive, wearable cardiac monitors that are seeing increased usage. This is the Cardiac Insight Cardea Solo device. After the monitoring period is over, the wearable patch is torn open to retrieve a data pod that is inserted into a reader to download the data. The software automatically creates reports based on the data, complete with waveforms for various cardiac measures.
Blog | Cardiac Diagnostics | May 10, 2018
Technology | Analytics Software | May 16, 2019
May 16, 2019 — Johnson & Johnson Medical Devices Companies announced the launch of Biosense Webster Inc.’s...
Data from the first-in-human use of Medtronic's extravascular ICD (EV-ICD) system was presented at HRS 2019.
Blog | HRS | May 16, 2019
The Heart Rhythm Society (HRS) 2019 Annual...
News | Ablation Systems | May 16, 2019
May 16, 2019 — Johnson & Johnson Medical Devices Companies announced that Biosense Webster, Inc.’s QDot Micro...
News | Ablation Systems | May 16, 2019
May 16, 2019 — CardioFocus Inc. announced the presentation of results from its...
Technology | Catheters | May 16, 2019
May 16, 2019 — BioCardia Inc. announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Avance...
Feature | HRS | May 15, 2019 | Dave Fornell, Editor
May 15, 2019 — The Heart Rhythm Society (HRS) had 21 late-...
Electromechanical Wave Imaging (EWI) is a new, high-frame rate 3-D rendered ultrasound technique that can noninvasively map the electromechanical activation of heart rhythm. This example shows the ECG tracings compared to the EWI image of the heart.
Feature | EP Mapping and Imaging Systems | May 15, 2019 | Dave Fornell, Editor
May 15, 2019 — A new study shows electromechanical wave imaging is capable of localizing arrhythmias including...
![A new infection risk scoring system has been developed based on data from the large PADIT Trial.[1] The new scoring system was presented as a follow up to that study during a late-breaking session at Heart Rhythm 2019, the Heart Rhythm Society's 40th Annual Scientific Sessions.](https://sgcweb.s3.wasabisys.com/dicardiology/s3fs-public/styles/content_feed_medium/public/PADIT_Infection_Risk_score.jpg?itok=sF0KB0mC)
Figure 1: The PADIT infection risk score ranging from 0 to 14 points classified patients into three risk groups, low (0-4), intermediate (5-6) and high (≥7). The risk groups had rates of hospitalization for infection of 0.51%, 1.42% and 3.41%, respectively
News | EP Lab | May 15, 2019
May 15, 2019 — A new infection risk scoring system has been developed based on data from the large PADIT Trial.[1]...
